Nail psoriasis in China: A prospective multicentre study

作者:Wang, Shiqi; Zhu, Jianjian; Wang, Ping; Dong, Jing; Li, Yanling; Shi, Dongmei; Wang, Huiping; Huang, Xi; Zhang, Xibao; Yu, Bo; Yang, Ziliang; Chen, Rixin; Wang, Xiaopeng; Li, Fuqiu; Bian, Kunpeng; Huo, Yuping; Yu, Nan; Li, Chen; Xia, Xiujuan; Lu, Jiejie; Li, Junjie; Lu, Yonghong; Xu, Yonghao; Ding, Yuan; Li, Yuzhen; Kang, Xiaojing; Li, Ruoyu*
来源:JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023.
DOI:10.1111/jdv.19684

摘要

BackgroundData on nail psoriasis (PsO) in China are scarce.ObjectivesTo provide nail PsO-related data regarding epidemiologic characteristics, manifestations, fungal infections, arthritic complaints and treatments that may facilitate improved patient management globally.MethodsFrom August 2021 to August 2022, patients with nail PsO were enrolled in a prospective multicentre observational study at 25 hospitals in China. We collected and analysed data concerning nail PsO demography, clinical signs, fungal detection, arthritic symptoms and treatment.ResultsA total of 817 patients with nail PsO were involved, with a mean body mass index of 24.13 +/- 2.93. In addition, 71.41% of the patients were male. The Nail PsO Severity Index score was weakly positively correlated with body surface area. The percentage of nail involvement was 95.29% for fingernails and 57.18% for toenails, with pitting (67.11%) and subungual hyperkeratosis (60.40%) being the most prevalent manifestations, respectively. Toenails showed a significantly higher frequency of nailfold scales, subungual hyperkeratosis and nail plate crumbling and a lower frequency of splinter haemorrhages, pitting and erythema of the lunula. A total of 13.26% of the PsO patients had onychomycosis, and 77.08% were observed in the toenails. Articular symptoms were reported by 12.17% of the patients, with the peripheral type being predominant. Significant associations between articular symptoms and nailfold swelling, subungual hyperkeratosis, nailfold scales, onycholysis and longitudinal ridges were found. Only 2.30% (20 out of 871) of patients with nail PsO received treatment. The most frequently employed therapy for cutaneous PsO with nail involvement was biologic therapy (n = 366).ConclusionsPsO showed distinct manifestations in the toenails and fingernails. Additionally, toenail PsO combined with onychomycosis requires special attention. Articular symptoms in psoriatic patients are associated with specific nail changes. It is important to research and advocate for more potent treatments for nail PsO.

  • 单位
    吉林大学; 东莞市人民医院; 哈尔滨医科大学; 苏州大学; 北京大学; 西安交通大学; 河北医科大学; 1; 山东大学

全文